Quick Answer
UiPath, Inc. reported Research And Development Expense of $385.21 million for the year ending 2026.
- UiPath, Inc. showed an increase of +1.2% in Research And Development Expense from 2025 to 2026.
- This data is from UiPath, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2026 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $26.73 million | Q3 2020: $26.54 million | Q4 2020: $27.46 million | Q2 2021: $93.04 million | Q3 2021: $57.65 million | Q4 2021: $61.56 million | Q2 2022: $68.69 million | Q3 2022: $67.85 million | Q4 2022: $67.34 million | Q2 2023: $75.34 million | Q3 2023: $86.61 million | Q4 2023: $84.51 million | Q2 2024: $85.60 million | Q3 2024: $98.43 million | Q4 2024: $96.98 million | Q2 2025: $94.84 million | Q3 2025: $98.34 million | Q4 2025: $96.87 million.
- Over the full 7 years of available data (2020 to 2026), UiPath, Inc.'s Research And Development Expense has grown by 193.9%.
- Historical annual values: Fiscal year 2026: $385.21 million | Fiscal year 2025: $380.68 million | Fiscal year 2024: $332.10 million | Fiscal year 2023: $285.75 million | Fiscal year 2022: $276.66 million | Fiscal year 2021: $109.92 million | Fiscal year 2020: $131.07 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: